Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2019-2028


Summary

The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Key Highlights

  • Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $261.5 billion in 2023. China was the fastest growing country with a CAGR of 7.2% over the 2019-23 period.
  • Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $161.0 billion in 2023. This was followed by India, Brazil and Russia with a value of $48.0, $30.7, and $21.8 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $217.4 billion in 2028, followed by India, Brazil, Russia with expected values of $56.0, $34.9 and $27.6 billion, respectively.




Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
  • Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country




Reasons To Buy

  • What was the size of the BRIC pharmaceuticals market by value in 2023?
  • What will be the size of the BRIC pharmaceuticals market in 2028?
  • What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the BRIC pharmaceuticals market?